Through univariate and multivariate Cox analyses, the researchers identified six genes (C6orf222, CCNL1, CREBZF, GCKR, TFCP2, and VIPR2) that are differentially methylated and associated with prognosis in GC patients receiving chemotherapy. Here, CREBZF is linked to gastric cancer.